SC Statement – Colombia, Dolutegravir, 3 de octubre de 2023
Colombia declara de interés público el uso de patente sobre Dolutegravir para incrementar el acceso a tratamiento a personas que viven con HIV 3 de octubre de 2023 El South Centre, el organismo...
View ArticleDocumento de investigación 186, 14 de noviembre de 2023
Patentamiento de anticuerpos monoclonales. El caso de Argentina Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini Este documento de investigación tiene como objeto...
View ArticleResearch Paper 188, 7 December 2023
The Intersection Between Intellectual Property, Public Health and Access to Climate-Related Technologies By Lívia Regina Batista On the 20th anniversary of the Doha Declaration on the Agreement on...
View ArticleResearch Paper 190, 24 January 2024
Implementing the Doha Declaration in OAPI Legislation: Do Transition Periods Matter? By Patrick Juvet Lowé Gnintedem The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS...
View ArticleResearch Paper 191, 25 January 2024
TRIPS Waiver Decision for Equitable Access to Medical Countermeasures in the Pandemic: COVID-19 Diagnostics and Therapeutics By Nirmalya Syam and Muhammad Zaheer Abbas, PhD The Marrakesh Agreement...
View ArticleDocumento de investigación 192, 30 de enero de 2024
Pautas para el examen de patentes sobre anticuerpos monoclonales Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini La investigación tiene como objetivo conocer el estado...
View ArticlePolicy Brief 125, 12 February 2024
WTO MC13: TRIPS Issues and Technology Transfer by Viviana Munoz Tellez, Nirmalya Syam This Policy Brief discusses issues concerning trade, intellectual property, and technology transfer that are most...
View ArticleResearch Paper 194, 15 February 2024
Implementation of TRIPS Flexibilities and Injunctions: A Case Study of India by Shirin Syed The proponents of intellectual property (IP) have increasingly utilized injunctions with indiscriminate...
View ArticleSouthViews No. 256, 22 February 2024
How Should the WHO Pandemic Treaty Negotiations Tackle Intellectual Property? By Viviana Muñoz Tellez The WHO pandemic instrument should commit the Parties to limit the exclusionary effects that...
View ArticleDocumento de investigación 195, 6 de marzo de 2024
Régimen de licencias obligatorias y uso público no comercial en Argentina Por Juan Ignacio Correa Con la adopción del Acuerdo sobre los Aspectos de Propiedad Intelectual relacionados con el Comercio...
View ArticleSouthViews No. 258, 11 March 2024
New US Policy on Exercise of March-In Rights to Curb High Drug Prices: Lessons for the Global South By Nirmalya Syam In response to soaring prescription drug costs, the United States government...
View ArticleClik here to view.
Co-Branded Event at the 2nd G-20 Health Working Group Meeting, 9 April 2024
Building Resilience for Health Emergencies, Pandemics and One Health Co-Branded Event hosted by the South Centre at the 2nd G-20 Health Working Group Meeting 6:30 – 8:00 pm, 9 April 2024 Brasilia,...
View Article